Volume-4 ~ Issue-1
- Citation
- Abstract
- Reference
- Full PDF
Key words: Blood pressure, famer, body mass index, systolic, diastolic, peak flow rate
Hill. 14, 2001) 442-444.
[2] T.D. Jardins, (2002). Exercise and its effect on cardiopulmonary system In: Cadiopulmonary anatomy and physiology, 4th ed.
(Delmar. 17, 2002) 443-454.
[3] D. Louie, "The effects of cigarette smoking on cardiopulmonary function and exercise tolerance in teenagers," Canadian
Respiratory: Journal of the Canadian Thoracic Society 8(4), 2001, 289-91.
[4] R.C. Duncan, R.G. Knapp and M.C. Miller, Test of hypothesis in population means. In: Introductory Biostatistics for the health
sciences. (John Wiley and Sons Inc. NY, 1977) pp. 71-96.
- Citation
- Abstract
- Reference
- Full PDF
Keyword: Bleeding time, Clotting time, Monosodium glutamate, Platelet count, Thrombocytopenia, Male rats.
[2] Allen .D., Delohery J., and Baker G.,: Monosodium L-glutamate InducedbAsthmas. Journal of Allergy Clinical Immunology. Vol 80 (4) 1987.530-537.
[3] Arauz-Contreras J and Feria-Velasco A.,: Monosodium L-glutamate induced convulsions. Differences in seizure pattern and duration of effect as a function of age in rats. Journal of General Pharmacology. Vol 15(5) 1984:391-395.
[4] Belluardo. M, Mudo. G, Bindoni. M : Effect of early destruction of mouse arcuate nucleus by MSG on age depended natural killer activity. Journal of Brain Research. Vol 534 1990: 225-333.
[5] Biodun. D, and Biodun. A. : A spice or poison? Is Monosodium glutamate safe for human consumption? Natural Concord Newspaper. Vol 4. 1993. 5.
[6] Brecher .G, and Cronkite, E.P. : Morphorlogy and enumeration of human blood platelets. Journal of Applied Physiology. Vol 3. 1950. 365.
[7] Bunyan .J, Murrell, E.A and Shah, P.P. : The induction of obesity in students by means of monosodium glutamate. British Journal of Nutrition. Vol 35(1). 1976: 25-39.
[8] Chambille. I, and Serviere. J. : Neurotoxic effects of neonatal injections of monosodium L-glutamate (L-MSG) on the retinal ganglion cell layer of golden hamster: anatomical and functional consequences on the circadian system. Journal of Neurology. Vol 338(1). 1993. 67-82.
[9] Corder. R, Saundan. P, Mazlan. M, Mclean. C, Gaillard. R.C. : Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats. Journal of Neuroendocrinology. Vol 51(1). 1993. 85-92.
[10] Daabees. T : Correlation of glutamate plus asparte dose amino acid concentration and neuronal necrosis in infant mice. Journal of Food Chemistry and Toxicology. Vol 23(10): 1985.887-893.
- Citation
- Abstract
- Reference
- Full PDF
Key Words:Area under curve (AUC), Beer's law, Derivative Spectrophotometry, Isoxsuprine hydrochloride, Q-Absorbance ratio
[2] Revanasiddappa HD,Manju BG Spectrophotometric determination of ritodrine and isoxsuprine hydrochlorides using 4-aminoantipyrine. Journal of AOAC International [2000, 83(6):1440-5]
[3] J M Bosken, A F Lehner, A Hunsucker, J D Harkins, W E Woods, W Karpiesiuk, W G Carter, J Boyles, M Fisher, andT Tobin Direct MS-MS identification of isoxsuprine –glucuronide in post administration equine urine.Arzneimittelforschung,2010 : 60(7):415-20. [4] J.M. Bosken†, A.F. Lehner, C.G. Hughes, W.E. Woods, F.C. Camargo,J.D. Harkins,J. Boyles,T. Tobin A GC-MS Method for the Determination of Isoxsuprine in Biological Fluids of the Horse Utilizing Electron Impact Ionization
[5] Priyadarshini J, Giji GP, Niraimathi V, Jerad Suresh A UV spectrophotometric estimation of metaxalone in bulk and tablet dosage form. Int. Journal of Chemical Sciences 2010; 8(2):1041-1045.
[6] Niraimathi V, Jerad Suresh A, Nanjappan K Spectrophotometric estimation of Nislodipine in bulk and tablet dosage formulation. Acta Ciencia Indica 2010; xxxvi C(4):393.
[7] Pharmacopeia: Vol 2; 2010. p.1527-1529s
[8] Jeffery GH, Bassett J, Mendham J and Denney RC. Vogel's Textbook of Quantitative Chemical Analysis. Fifth edition, New York, Longman Scientific & Technical with John Wiley & Sons, p 668-670.
[9] Beckett AH and Stenlake JB. Practical Pharmaceutical Chemistry. Part two. Fourth edition, New Delhi, CBS publisher., p 296-300.
[10] Smita T.Kumbhar, Swapnil D. Jadhav, Neela M. Bhatia, Manish S. Bhatia. Development and validation of derivative spectrophotometric method for estimation of atorvastatin calcium and amlodipine besylate in tablet dosage form. Int J Pharmacy and Pharm Sci 2011; 3(4): 195-197.
- Citation
- Abstract
- Reference
- Full PDF
Key words::Antifungal potential, Fusarium oxysporum, Chenopodium ambrosioides, plant extracts.
[1] Barnard, C; Padgitt, M. and Uri, N.D. (1997). Pesticide use and its measurement. International Pest Control 39:161-164.
[2] Gottlieb, O.R; Borin, M.R. and Brito, N.R. (2002) Integration of ethnobotany and phytochemistry: dream or reality? Phytochemistry 60:145-152.
[3] Perez C, Paul M, Bazerque P, (1990). Acta Bio Med Exp 15:113-115.
[4] Singh, J and Tripathi, N.N. (1999). Inhibition of storage fungi of blackgram ( Vigna mungo) by some essential oils. Flavour and Fragrance Journal 14: 1-4.
[5] Verma, J. and Dubey, N.K. (1999). Prospectives of botanical and microbial products as pesticides of tomorrow. Current Science 76; 172-179.
[6] Vishwadhar, Gurha SN (1998). Integrated management of Chickpea diseases. Integrated pest and disease management. Rajeev, k; Upadhyay, K.G; Mukerji, B.P; Chamola and Dubey, O.P. (eds.) APH Publishing Co; New Delhi. (India). P.249.
- Citation
- Abstract
- Reference
- Full PDF
Paper Type | : | Research Paper |
Title | : | Preliminary phytochemical analysis of leaf of Garcinia gummi-gutta from Western Ghats. |
Country | : | India |
Authors | : | Madappa M.B, A.K.Bopaiah |
: | 10.9790/3008-0411727 |
Key Words:Ethnomedicinal properties, Garcinia gummi-gutta, location, phytochemical analysis, secondary metabolites.
[1] Marjorie Murphy Cowan, Plant products as antimicrobial agents, Clinical Microbiol. Rev, vol. 12 no. 4,1999, 564-582
[2] Rajasab, A.H.2004, Indian Journal of Traditional Knowledge.vol.3(4). Mopr.Niscair.res.in
[3] R. Hegnaijer,Chemical characters in plant taxonomy:some possibilities and limitations, laboratoriuin voor experimentele plantensystematiek, leiden, Netherlands.
[4] Dmitriy Obolskiy, Ivo Pischel, Nisarat Siriwatanametanon, Michael Heinrich, Phytotherapy research, Vol 23, Issue 8, 2009, 1047–1065.
[5] J. S. Kayembe, K. M. Taba, K. Ntumba, M. T. C. Tshiongo and T. K. Kazadi In vitro anti-malarial activity of 20 quinones isolated from four plants used by traditional healers in the Democratic Republic of Congo, Journal of Medicinal Plants Research Vol. 4(11), 2010, 991-994.
[6] Ramesh BR, Pascal JP. Atlas of endemics of the Western Ghats (India): distribution of tree species in the evergreen and semi-evergreen forests. Institut Francais de Pondichery iv, 1997, 403.
[7] Carlos A. R. Vasques,Simone Rossetto, Graziele Halmenschlager, Rafael Linden, Eliane Heckler, Maria S. Poblador Fernandez, José L. Lancho Alonso , Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity, Phytotherapy Research,Volume 22, Issue 9, 2008, 1135–1140.
[8] M. Hemshekhar, K. Sunitha, M. Sebastin Santhosh, S. Devaraja, K. Kemparaju, B. S. Vishwanath, S. R. Niranjana, K. S. Girish , An overview on genus garcinia: phytochemical and therapeutical aspects.Phytochemistry Reviews, Volume 10, Issue 3, 2011, 325-351.
[9] V. N. Neelakandan, C. N. Mohanan , B. Sukumar. A bio-geographical information system. Centre for earth science studies2010.www. incaindia.org
[10] C. MohananGeorge Mathew,Plantation technology for selected indigenous trees in the Indian peninsula , Bois et forêts des tropiques(3), 2005, 285.
- Citation
- Abstract
- Reference
- Full PDF
Paper Type | : | Research Paper |
Title | : | Metabolic Syndrome in Hypertensive Nigerians: Risk Factor Analysis |
Country | : | Nigeria |
Authors | : | Innocent S. I. Ogbu, Emmanuel Ike Ugwuja |
: | 10.9790/3008-0412832 |
Key Words:Metabolic syndrome, ATP III criteria, dyslipidaemia, hyperglycaemia, hypertensive Nigerians.
[1] Barclay, L. New definition of the metabolic syndrome. A newsmaker Interview with Sir George Alberti. Available at:
[2] http://www.mediscape.com/viewarticle/504382?scr=hp22lead (Accessed 05/12/09).
[3] World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of W.H.O. Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus 1999. World Health Organization Department of Noncommunicable Disease Surveillance, Geneva. Available at: http://whqlibdoc.who.int/hqr/1999/who_ncd_ncs_99.2.pdf. (Accessed on 12/8/2011).
[4] National Cholesterol Education Programme. 3rd Report of the NCEP on Detection and Treatment of high Blood Cholesterol in (Adults, Adult Treatment Panel III); final report. Circulation 2002; 106: 3143 – 3421.
[5] Alberti, K.G.M, Zimmet, P., Shaw, J. Metabolic syndrome: A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Med. 2006; 23: 469 – 480.
[6] Alberti, K.G.M. and Zimmet, P. and Shaw, J. International Diabetic Federation, (IDF), Epidemiology Task Force Consensus Group. The Metabolic Syndrome – a new worldwide definition. Lancet 2005; 366: 1059 – 1062.
[7] Alberti, K. G., Eckel, R. H., Grundy, S. M. et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Blood and Lung Institute; American Heart Association; World Heart Federation International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640 – 1645.
[8] Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R. and Tracy, R. P. Clustering of procoagulation, inflammation and fibrinolysis variables with metabolic factor in insulin resistance syndrome. Am J Epidemiol 2001; 152: 897 – 907.
[9] Chen, W. Srinivasan, S. R. Elkasabany, A. and Berenson, G. S. Cardiovascular risk factor clustering features of insulin resistance syndrome, (Syndrome X) in a biracial (blck-white) population of children, adolescents and young adults: The Bogahisa Heart Study. Am J Epidemiol 1999; 150: 667 – 674.
[10] Gray, R. S. Fabsitz, R. R. Cowan, L. D. Lee, E. T. Howard, B. V. and Savage, P. J. Risk factor clustering in the insulin resistance syndrome: The Strong Heart Study. Am J Epidemiol 1998; 148: 869 – 878.
- Citation
- Abstract
- Reference
- Full PDF
Paper Type | : | Research Paper |
Title | : | Fabry Disease: from Diagnosis to Therapy |
Country | : | Pakistan |
Authors | : | Ifrah Shafqat and Dr. Shaheen Shahzad |
: | 10.9790/3008-0413338 |
Key Words:α-Galactosidase A (AGAL), chaperon therapy, fabry disease, glycoshingolipids, lysosomal storage disease
[1] K.D. MacDermot, A. Holmes, and A.H. Miners, Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 98 hemizygous males, Journal of Medical Genetics, 38(11), 2001, 750–760.
[2] W.J. Cable, E.H. Kolodny, and R.D. Adams, Fabry disease: impaired autonomic function, Neurology, 32(5), 1982, 498–502.
[3] M. Ries, U. Ramaswami, R. Parini, B. Lindblad, C. Whybra, I. Willers, A. Gal, and M. Beck, The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents, European Journal of Pediatrics, 162(11), 2003, 767-772.
[4] D. Hajioff, Y. Enever, R. Quiney, J. Zuckerman, K. Mackermot, and A. Mehta, Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy, Journal of Inherited Metabolic Disease, 26(8), 2003, 787-794.
[5] D.M. Rosenberg, V.J. Ferrans, J.D. Fulmer, B.R. Line, J.A. Barranger, and R.O. Brady, Chronic airflow obstruction in Fabry's disease, The American Journal of Medicine, 68(6), 1980, 898-905.
[6] S. Ishii, H.H. Chang, K. Kawasaki, K. Yasuda, H.L. Wu, S.C. Garman, and J.Q. Fan, Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1- deoxygalactonojirimycin, The Biochemical Journal, 406(2), 2007, 285-295.
[7] B. Sachdev, T. Takenaka, H. Teraguchi, C. Tei, P. Lee, and W.J. McKenna, Prevalence of Anderson–Fabry disease in male patients with late onset hypertrophic cardiomyopathy, Circulation, 105(12), 2002, 1407–1411.
[8] S. Nakao, C. Kodama, T. Takenaka, A. Tanaka, Y. Yasumoto, A. Yoshida, T. Kanzaki, A.L. Enriquez, C.M. Eng, H. Tanaka, C. Tei, and R.J. Desnick, Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype, Kidney International, 64(3), 2003, 801-807.
[9] C.C. Sweeley, and B. Klionsky, Fabrys disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid, The Journal of Biological Chemistry, 238, 1963, 3148-3150.
- Citation
- Abstract
- Reference
- Full PDF
Key Words:Maize/Soya, Complementary Food, Processing, Nutrients.
[1] AOAC (1990): Official Methods of Analysis (15th Edition). Association of official Analytical Chemist. Washington DC. USA.
[2] Akinrele, I. A. and Edward, C. (1971): An assessment of the nutritional value of maize soy mixture Soya Ogi as a complementary food in Nigeria Br. J. Nutrition 26: 172 – 185.
[3] Alexia, J. M. (2007): Effect of sprouting on nutrient composition and some anti-nutritional factor of sorghum and soybean J. Food chemistry, Vol. 101: 1202 – 2111.
[4] David Pearson (1976): The Chemical Analysis of Food. National College of Food Technology, University of Reading, 7th Edition Church Hill Living Stone, Edinburgh and New York, Pg. 214 – 215.
[5] Desikarcher, H. S. R. (1989): Cooking behaviour of Semoling from maize, sorghum, wheat and rice journal of food science and Technology 13: 34 – 36.
[6] Ejigni, J.; Savoie, L. Marim J. and Desrosiers, T. (2007): Improvement of the nutritional quality of a traditional complementary porridge made of fermented yellow maize: Effect of maize – legume combinations and traditional processing methods. Food Nutri. Bull. 28(1): 23 – 34.
[7] Fashakin, J. B. and Ogunsola, F. (1982): The utilization of local foods in formulation of weaning foods. Trop Paediatr Land 1982: 28: 93 – 6.
[8] Gopalan ad Srikantia (1973): Nutrition and Disease. World Rev. Nutr. Diet 1973: 16: 97 – 140.
[9] Guiro, A. T.; Sail, M. G.; Kane, O.; Ndeaye, A. M.; Diarlia, D. (1987): Protein – calorie malnutrition in Senegalese children – Effect of rehabilitation with Pearl Millet Complementary Food. Nutr. Reg. Int. 36: 107 – 109.
[10] Hegested, D. M. (1970): Theoretical estimates of protein requirement of children, protein in Nutrition Academic Press Inc.
- Citation
- Abstract
- Reference
- Full PDF
Key Words:Convulsion, Epilepsy, Mice, Pentylenetetrazole, Securinega virosa, seizure
[1] M.L.Scheuer and T. A. Pedley, The evaluation and treatment of seizures. New Engl J Med.; (323), 1990, 1468–74. [2] P. Kamboj, I. Singh, N. Mahadevan and G. Chaudhary, Anticonvulsants from nature. Phcog Rev.; 3(5), 2009, 108–17. [3] C. G. Goet and E. J. Pappert, Text book of clinical Neurology 2nd ed. (Philadelphia, pa: Saunders, 2003). [4] K. Suresh, M. Reecha, B. Gundeep, J. Anupam and S. Anupam, Plants and Plant Products with Potential Anticonvulsant Activity – A Review. Pharmacognosy Communications Volume (2), 2012, Issue (1) Suppl. [5] X. Lin, R. Nicholas, Y. Xiao-Feng, X. Z. Hai, L.T. Liu, M.R. Steven, E.W. Aryan, W. Michael and A.Y. Kelvin A. Y, Leptin inhibits 4-aminopyridine– and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. Journal of Clinical Investigatio, .118 (1), 2008, 272–280.
[6] A. Atif, J.A. Farhan, K .P. Krishna, and V. Divya, Amiloride protects against pentylenetetrazole-induced kindling in mice, British Journal of Pharmacology; 145(7), 2005, 880–884. [7] J. Engel, A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia, (42), 2001, 796-803. [8] P.O. Fabeku, Traditional Medicine: the art, ways and practice. In: Odugbemi, T, editor, Outlines and Pictures of Medicinal Plants from Nigeria, (University of Lagos Pres, .2006) 13-24. [9] J.D. Neuwinger, Translated from by Porter A. African ethnobotany poison and drugs, (Chapman and Hall, Weinheim, 1996) pp. 495-499. [10] Y. Tanko, M.A. Okasha, G. M. Magaji, M. Yerima, A.H. Yaro,M.I.A. Saleh and A. Mohammed, Anti-diabetic properties of Securinega virosa (Euphorbiaceae) leaf extract. African Journal of Biotechnology, Vol. 7 (1), 2008, pp. 022-024.
- Citation
- Abstract
- Reference
- Full PDF
Key Words:Jussiaea nervosa, Cd-intoxication, haematoprotection, nephroprotection
[1] International Agency for Research on Cancer (IARC). 1993. Berylium, cadmium, mercury and exposures in Glass Manufacturing Industry in Monographs on the evaluation of carcinogenic risk. Human Scientific Publications (58): 119-237
[2] Bem, E.M., Piotrowski., J.K., and Turzynska., T. 1993. Cadmium, zinc and copper levels in the kidneys and liver of the inhabitants of North-Eastern Poland Journal of Occupational Medicare and Environmental Health (6):133-141.
[3] World Health Organization. 1992. Environmental health criteria, 134, cadmium. Geneva: World Health Organization; Pp 111–2
. [4] Latif, A., Ahmad, H., Begum, S., Hussian, S.K., and Adnan, M. 2004. Medicinal and other economic plants as substitute to forest logging in miandam and sulatann valley-Swat. Bioactive molecules and medicinal plants 54(4): 349-369.
[5] Sofowora, A. 1986. The State of Medicinal Plants in Nigeria. University of Ibadan Press, Ibadan. Pp 419.
[6] Sadiq, D., Ezi-Ashi, T., and Onuaguluchi, G. 2003. Checklist of medicinal plants of Nigeria and their uses. 1st edition. A publication of the Association Conservation and Utilization of Medicinal Plants in Nigeria, Asicumptipn Enugu, Nigeria Pp 64-73.
[7] Sofowora A. (1997). The State of Medicinal Plants 1st edition. University of Ibadan, Press Nigeria, Pp 286.
[8] National Research Council (NRC). 1985. Guide for the care and use of laboratory animals. Publication No. 8523 (Rev), National Institute of Health, Bethesda, MD.
[9] Dacie JV and Lewis SM. 1995. Practical haematology 8th edition Edinburgh: Churchill Livingstone
[10] Jung D, Briggs N, Erickson J, Ledyard P. 1975. New colorimetric reaction for nd-point continuous flow, and kinetic measurement of urea. Clin Chem 21: 11-36.
- Citation
- Abstract
- Reference
- Full PDF
Key Words:Bioremediation, microorganisms, extracellular hydrolytic enzymes, enzyme assay
[1] Buzzini, P. and Martini, A. (2002): Extracellular enzymatic activity profiles in yeast and yeast like strains isolated from tropical
environments. J.Appl. Microbial., 93:1020-1025.
[2] Chandrakant, S. Karigar. and Shwetha S. Rao. (2011)Role of Microbial Enzymes in the Bioremediation of Pollutants: Enzyme R,
11: 1-11
[3] Colin, Scott. , Steve, E. Lewis ., Rob, Milla. , Matthew, C. Taylor. , Andrew,J.W. Rodgers. , Geoff, Dumsday .,Jon, E. Brodie. ,
John, G. Oakeshott. , Robyn, J. Russell. (2010) A free-enzyme catalyst for the bioremediation of environmental atrazine
contamination. J Environ Manage, 91 : 2075-2078
[4] Gupta, S., Krishna, M., Prasad, R.K., Gupta, S., Kansal, A. (1998). Solid waste management in India: options and opportunities.
Resour Conservat Recycl ,24: 137–154.
[5] Kelly,C.T.,Fogarty,W.M. (1983) Microbial glucidase P Biochem, 18:315-320
[6] Lal ,R., Saxena, D. M. (1982) Accumulation, metabolism andeffects of organochlorine insecticides on microorganisms, Microbiol
Rev, 46: 95–127,
[7] LiH. Dang _ H, T, Zhu _ J. Wang (2009) Extracellular hydrolytic enzyme screening of culturableheterotrophic bacteria from deepsea
sedimentsof the Southern Okinawa TroughWorld J. Microbiol. Biotechnol, 25:71–79
[8] Rathi, S. (2006). Alternative approaches for better municipal solid waste management in Mumbai, India. J Waste Manage, 26:
1192–1200.
[9] S´anchez-Porro, C., Mart´ın, S., Mellado, E., Ventosa, A. (2003). Diversity of moderately halophilic bacteria producing
extracellular hydrolytic enzymes, J Applied Microbiolo, 94: 295–300
[10] Sharma, S., Shah, K.W. (2005). Generation and disposal of solid waste in Hoshangabad. In: Book of Proceedings of the Second
International Congress of Chemistry and Environment, Indore, India, pp. 749–751